Circulating microRNAs as potential new biomarkers for prostate cancer

A Sita-Lumsden1, D A Dart, J Waxman

  • 1Androgen Signalling Laboratory, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.

Summary

Circulating microRNAs (miRNAs) show promise as biomarkers for prostate cancer, offering a potential improvement over current diagnostic tests. These stable molecules detected in biofluids could help distinguish aggressive cancers from slow-growing ones.